Chronic Lymphocytic Leukemia Highlights From ASH 2023 Chronic Lymphocytic Leukemia Highlights From ASH 2023
Doublet and triplet therapies as well as strong results from late-generation BTK inhibitors and sequencing are among CLL highlights from ASH 2023, as reported by Dr John Allan.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Health | Hematology | Leukemia